CJC-1295 no DAC (5mg) + IPA (5mg)

This blend combines two well-characterized peptides commonly used in laboratory research to investigate growth hormone secretagogue pathways.

CJC-1295 (No DAC) is a tetrasubstituted analog of growth hormone–releasing hormone (GHRH). The absence of DAC results in a shorter functional half-life, making it suitable for studying pulsatile growth hormone release patterns and endogenous GH signaling dynamics.

Ipamorelin is a selective ghrelin receptor agonist that has been studied for its ability to stimulate growth hormone release in vitro, with research indicating minimal interaction with prolactin or cortisol secretion pathways.

When used together, this blend provides researchers with a complementary model system for examining growth hormone–related signaling mechanisms, receptor interactions, and downstream cellular responses under controlled experimental conditions.